President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
JetBlue made an unsolicited offer to buy low-cost carrier Spirit Airlines, potentially jeopardizing the original offer from Frontier Airlines. Several analysts sounding the alarm on JetBlue's proposed $3.6 billion merger, saying the deal doesn't quite make sense. Jim Corridore, Senior Insights Manager at Similarweb joined Cheddar's Opening Bell to discuss.
The Biden administration is once again extending the pause on federal student loans payments — this time, through the end of August. In a statement, President Biden cited a recent analysis from the Fed that if the payments were to resume, millions of student loan borrowers would face significant "economic hardship, delinquencies, and defaults that could threaten America's financial stability." Sarah Foster, an analyst at Bankrate, breaks down the impact of the extension on borrowers, the economy, and the future of student loan forgiveness. "I think this is just an instance of the federal student loan forbearance program kind of creating additional uncertainty for borrowers, especially in the sense that these past four extensions from the Biden administration have kind of come at the 11th hour here," she said.
Thousands of cryptocurrency enthusiasts are gathering in Miami as the city builds its reputation as one of the key locations to develop the blockchain technology despite its underdog status.
Catching you up on what you need to know on April 7, 2022, with updates on Ukraine urging NATO for military aid for their war with Russia, the SEC investigating Amazon, microplastics being found deep inside human lungs for the first time, and more.
President Biden is trying to help Americans at the pump by tapping into U.S. oil reserves in an unprecedented way. He also announced several steps to punish oil companies. Lisa Whalen, automotive and mobility analyst at Morning Consult, joins Cheddar News to discuss.
U.S. markets closed higher to end Monday's session, with tech stocks leading the advance. Gene Goldman, Chief Investment Officer at Cetera Financial Group, joins Cheddar News' Closing Bell to discuss the potential future of the major U.S. indexes, and how factors like policy moves from the federal reserve and the ongoing Ukraine-Russia war could impact volatility.
Prices at the pump have soared in recent months, and House Democrats pointed the finger at Big Oil on Wednesday during an adversarial congressional hearing.
Catching you up on what you need to know on April 6, 2022, with updates on the FDA’s meeting to discuss a second COVID booster shot, more on the war in Ukraine, tornadoes on the Gulf coast, a third suspect arrested in connection to the mass shooting in California, Darwin’s lost notebooks mysteriously returned, and more.
